{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T21:53:59Z","timestamp":1793483639026,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ijcard.2024.132477","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T02:24:29Z","timestamp":1724379869000},"page":"132477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Adverse events associated with early initiation of Eplerenone in patients hospitalized for acute heart failure"],"prefix":"10.1016","volume":"415","author":[{"given":"Masatake","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Yamashina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Satomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Tezuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Asakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Kitakaze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Pedro","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2024.132477_bb0005","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone evaluation study investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2024.132477_bb0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2024.132477_bb0015","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2024.132477_bb0020","doi-asserted-by":"crossref","DOI":"10.1111\/1755-5922.12459","article-title":"Obstacles to mineralocorticoid receptor antagonists in a community-based heart failure population","volume":"36","author":"Jonsson","year":"2018","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.ijcard.2024.132477_bb0025","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/ejhf.1182","article-title":"Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish heart failure registry","volume":"20","author":"Savarese","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2024.132477_bb0030","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/j.jacc.2020.04.021","article-title":"Abnormalities of potassium in heart failure: JACC state-of-the-art review","volume":"75","author":"Ferreira","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132477_bb0035","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/ndt\/gfae004","article-title":"When to use spironolactone, eplerenone or finerenone in the spectrum of cardiorenal diseases","volume":"39","author":"Kobayashi","year":"2024","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ijcard.2024.132477_bb0040","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2024.132477_bb0045","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1093\/eurheartj\/ehad617","article-title":"Acute heart failure: current pharmacological treatment and perspectives","volume":"44","author":"Deniau","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2024.132477_bb0050","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1056\/NEJMoa1601895","article-title":"Effect of Ularitide on cardiovascular mortality in acute heart failure","volume":"376","author":"Packer","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2024.132477_bb0055","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/ejhf.2982","article-title":"Mineralocorticoid receptor antagonist use and the effects of empagliflozin on clinical outcomes in patients admitted for acute heart failure: findings from EMPULSE","volume":"25","author":"Ferreira","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2024.132477_bb0060","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejim.2013.08.711","article-title":"Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure","volume":"25","author":"Ferreira","year":"2014","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.ijcard.2024.132477_bb0065","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/ejhf.2975","article-title":"Mineralocorticoid receptor antagonist initiation during admission is associated with improved outcomes irrespective of ejection fraction in patients with acute heart failure","volume":"25","author":"Beldhuis","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2024.132477_bb0070","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/ehjcvp\/pvaa132","article-title":"Efficacy and safety of early initiation of Eplerenone treatment in patients with acute heart failure (EARLIER trial): a multicentre, randomized, double-blind, placebo-controlled trial","volume":"8","author":"Asakura","year":"2022","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"10.1016\/j.ijcard.2024.132477_bb0075","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijcard.2022.12.045","article-title":"Effect of eplerenone on clinical stability of Japanese patients with acute heart failure","volume":"374","author":"Kobayashi","year":"2023","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132477_bb0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10557-014-6565-2","article-title":"Rationale and design of the double-blind, randomized, placebo-controlled multicenter trial on efficacy of early initiation of Eplerenone treatment in patients with acute heart failure (EARLIER)","volume":"29","author":"Asakura","year":"2015","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ijcard.2024.132477_bb0085","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2024.132477_bb0090","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/ejhf.2376","article-title":"Outpatient diuretic intensification as endpoint in heart failure with preserved ejection fraction trials: an analysis from TOPCAT","volume":"24","author":"Ferreira","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2024.132477_bb0095","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jamacardio.2017.2198","article-title":"Efficacy and safety of spironolactone in acute heart failure: the ATHENA-HF randomized clinical trial","volume":"2","author":"Butler","year":"2017","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2024.132477_bb0100","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/jamacardio.2017.4370","article-title":"Interpretation of the ATHENA trial-caveats and future directions","volume":"3","author":"Ferreira","year":"2018","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2024.132477_bb0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ejhf.1369","article-title":"The use of diuretics in heart failure with congestion - a position statement from the heart failure Association of the European Society of cardiology","volume":"21","author":"Mullens","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2024.132477_bb0110","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/eurjhf\/hfr060","article-title":"Early drop in systolic blood pressure and worsening renal function in acute heart failure: renal results of pre-RELAX-AHF","volume":"13","author":"Voors","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2024.132477_bb0115","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jchf.2014.11.004","article-title":"Early and late effects of high- versus low-dose angiotensin receptor blockade on renal function and outcomes in patients with chronic heart failure","volume":"3","author":"Kiernan","year":"2015","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcard.2024.132477_bb0120","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jchf.2021.12.005","article-title":"Renal compression in heart failure: the renal tamponade hypothesis","volume":"10","author":"Boorsma","year":"2022","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcard.2024.132477_bb0125","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jamacardio.2022.2924","article-title":"Association of empagliflozin treatment with albuminuria levels in patients with heart failure: a secondary analysis of EMPEROR-pooled","volume":"7","author":"Ferreira","year":"2022","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2024.132477_bb0130","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jacc.2022.10.028","article-title":"Albuminuria and heart failure: JACC state-of-the-art review","volume":"81","author":"Khan","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132477_bb0135","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/ejhf.1199","article-title":"Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists","volume":"20","author":"Trevisan","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2024.132477_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2022.08.009","article-title":"Heart failure drug treatment-inertia, titration, and discontinuation: a multinational observational study (EVOLUTION HF)","volume":"11","author":"Savarese","year":"2023","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcard.2024.132477_bb0145","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ahj.2013.03.007","article-title":"Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure","volume":"165","author":"Curtis","year":"2013","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2024.132477_bb0150","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/ejhf.2287","article-title":"Stopping mineralocorticoid receptor antagonists after hyperkalaemia: trial emulation in data from routine care","volume":"23","author":"Trevisan","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2024.132477_bb0155","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.acvd.2020.03.018","article-title":"Practical management of worsening renal function in outpatients with heart failure and reduced ejection fraction: statement from a panel of multidisciplinary experts and the heart failure working Group of the French Society of cardiology","volume":"113","author":"Mewton","year":"2020","journal-title":"Arch. Cardiovasc. Dis."},{"key":"10.1016\/j.ijcard.2024.132477_bb0160","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jamacardio.2016.4733","article-title":"Reduced risk of hyperkalemia during treatment of heart failure with mineralocorticoid receptor antagonists by use of Sacubitril\/valsartan compared with Enalapril: a secondary analysis of the PARADIGM-HF trial","volume":"2","author":"Desai","year":"2017","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2024.132477_bb0165","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1093\/eurheartj\/ehac306","article-title":"Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-pooled","volume":"43","author":"Ferreira","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2024.132477_bb0170","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.hfc.2022.03.006","article-title":"SGLT2 inhibitors in heart failure with reduced ejection fraction: a paradigm shift toward dual cardio-renal protection","volume":"18","author":"Rastogi","year":"2022","journal-title":"Heart Fail. Clin."},{"key":"10.1016\/j.ijcard.2024.132477_bb0175","first-page":"419","article-title":"Heart failure clinical trials in east and Southeast Asia: understanding the importance and defining the next steps. JACC","volume":"4","author":"Mentz","year":"2016","journal-title":"Heart Failure"},{"key":"10.1016\/j.ijcard.2024.132477_bb0180","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/ejhf.1585","article-title":"Heart failure around the world","volume":"21","author":"Tromp","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2024.132477_bb0185","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/eurjhf\/hfs145","article-title":"Predicting adverse events during angiotensin receptor blocker treatment in heart failure: results from the HEAAL trial","volume":"14","author":"Kiernan","year":"2012","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2024.132477_bb0190","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/clc.23576","article-title":"Perceived risk profile and treatment optimization in heart failure: an analysis from BIOlogy Study to TAilored Treatment in chronic heart failure","volume":"44","author":"Kobayashi","year":"2021","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132477_bb0195","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jchf.2018.02.004","article-title":"Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure","volume":"6","author":"Damman","year":"2018","journal-title":"JACC Heart Fail."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324010994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324010994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T00:17:42Z","timestamp":1726273062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527324010994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":39,"alternative-id":["S0167527324010994"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132477","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse events associated with early initiation of Eplerenone in patients hospitalized for acute heart failure","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132477","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"132477"}}